Non-pharmacological therapy and complementary and alternative medicine in Fibromyalgia

Revista Brasileira de Reumatologia

Volumn 51, Issue 3, 2011, Pages 269-282

  de Braz, Alessandra Sousa ^a   de Paula, Ana Patrícia ^b   de Diniz, Margareth Fátima F Melo ^c   de Almeida, Reinaldo Nóbrega ^d  

^a Faculdade de Medicina Nova Esperança   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c Department of Pharmacology of the UFPB ^*  (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Complementary therapies; Fibromyalgia; Phytotherapy

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CALCIUM CHANNEL AFFECTING AGENT; CYCLOBENZAPRINE; DEXTROMETHORPHAN; DULOXETINE; FLUOXETINE; GABAPENTIN; GINSENG EXTRACT; MILNACIPRAN; MUSCLE RELAXANT AGENT; NABILONE; PLACEBO; PRAMIPEXOLE; PREGABALIN; S ADENOSYLMETHIONINE; TRAMADOL; TROPISETRON;

ACUPUNCTURE; AEROBIC EXERCISE; ALTERNATIVE MEDICINE; ANXIETY; BIOLOGICAL THERAPY; CHINESE MEDICINE; CHLORELLA; CHLORELLA PYRENOIDOSA; CHRONIC PAIN; COGNITIVE THERAPY; DIET SUPPLEMENTATION; DRUG USE; EXERCISE; EXERCISE INTENSITY; FATIGUE; FIBROMYALGIA; GINSENG; HUMAN; HYPERICUM PERFORATUM; PHYSICAL ACTIVITY; PHYTOTHERAPY; REVIEW; SLEEP; UNSPECIFIED SIDE EFFECT; VEGETARIAN DIET; VISUAL ANALOG SCALE; WARM UP EXERCISE; WELLBEING;

COMPLEMENTARY THERAPIES; FIBROMYALGIA; HUMANS;

EID: 79958139082     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd Ed. Seattle: IASP Press, 1994.
2. Arias M. Es la fibromialgia una enfermidad neurológica? Neurologia 2008; 23:593-601.
3. Dadabhoy D, Clauw DJ. Fibromyalgia: progress in diagnosis and treatment. Curr pain headache reports 2006; 9:399-404.
4. Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997; 40:1928-1939.
5. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind up) in patients with fibromyalgia syndrome. Pain 2001; 91:165-175.
6. Staud R, Vierck CJ, Robinson ME, Price DD. Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J Pain 2005; 6:323-332.
7. Nielsen LA, Henriksson KG. Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition. Best Practice Res 2007; 21:465-480.
8. Dadabhoy D, Crofford LL, Spaeth M, Russell IJ, Clauw DJ. Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther 2008; 10:211.
9. Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetics aspects of fibromyalgia syndrome. Arthritis Res Ther 2006; 8:218-222.
10. Burckhardt CS, Clark SR, Bennet RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991; 18:728-733.
11. Martinez JE, Barauna Filho IS, Kubokawa K, Pedreira IS, Machado LA, Cevasco G. Análise crítica de parâmetros de qualidade de vida de pacientes com fibromialgia. Acta Fisiátrica 1998; 5:116-20.
12. Wolfe F, Hawley DJ, Goldenberg DL, Russell IJ, Buskila D. The assessment of functional impairment in fibromyalgia (FM): rasch analyses of 5 functional scales and the development of the fm health assessment questionnaire. J Rheumatol 2000; 7:1989-1999.
13. Perrot S, Dumont D, Guillemin F, Pouchot J, Coste J. Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the fibromyalgia impact questionnaire. J Rheumatol 2003; 30:1054-1059.
14. Picavet HS, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and Eq-5d in the DMC3 study. Ann Rheum Dis 2004; 63:723-729.
15. Marques AP, Santos AMB, Assumpção A, Matsutani LA, Lage LV, Pereira CAB. Validação da versão brasileira do Fibromyalgia impact questionaire (FIQ). Rev Bras Reumatol 2006; 46:24-31.
16. Crofford LJ, Appleton BE. Complementary and alternative therapies for fibromyalgia. Curr Rheumatol Reports 2001; 3:147-156.
17. Garcia-Campayo J, Magdalena J, Magallon R, Fernandez-Garcia E, Salas M, Andrés E. A meta-analysis of the efficacy of fibromyalgia treatment according to level of care. Arthritis Res Ther; [in press].
18. Hãuser W, Bernardy K, Üçeyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressant. A meta-analysis. JAMA 2009; 301:198-209.
19. Arnold LM. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med 2007; Suppll2:S63-S74.
20. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PEJR. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002; 112:191-197.
21. Gendreau M, Thorn M, Gendreau J, Kranzler J, Ribeiro S, Gracely R et al. Efficay of milnacipran in patients with fibromyalgia. J Rheumatol 2005; 32:1975-1985.
22. Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 2009; 36:398-409.
23. Bennet RM, Gatter R A, Campbell SM, Andrews RP, Clark SR, Scarola JA. A comparison of cyclobenzaprine and placebo in the management of fibrositis: a double-blind controlled study. Arthritis Rheum 1988; 31:1535-1542.
24. Carette S, Bell MJ, Reynoulds WJ, Haraqui B, Mccain GA, Bykerk VP et al. Comparison of amitriptyline, cyclobenzaprine and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 1994; 37:32-40.
25. Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE Jr. et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007a; 56:1336-1344.
26. Arnold LM, Russell IJ, Diri EW, Duan WR, Young JPJR, Sharma U et al. A 14-week, randomized, double-blind, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. Pain 2008; 9:792-805.
27. Mease PJ, Russell IJ, Arnold LM, Florian H, Young JPJR, Martin SA et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008; 35:502-514.
28. Russel J, Kamin M, Bennett R, Schnitzer T, Grenn J, Katz W. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol 2000; 6:250-257.
29. Bennet RM, Schein J, Kosinski MR, Hewitt DJ, Jordan DM, Rosenthal NR. Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 2005; 53:519-517.
30. Ginsberg F, Mancaux A, Joos E, Vanhove PH, Farmacy JP. A randomized placebo-controlled trial of sustained-release amitriptyline in primary fibromyalgia. Musculoskeletal Pain 1996; 4:37-47.
31. Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline and naproxene in the treatment of patients with fibromyalgia. Arthritis Rheum 1996; 29:1371-1377.
32. Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Raponen P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol 1998; 37:1279-1286.
33. Ozerbil O, Okuda N, Gokbel H, Levendoglu F. Comparison of the effects of two antidepressants on exercise performance of the female patients with fibromyalgia. Clin Rheumatol 2006; 25:495-497.
34. Arnold LM, Pritchett YL, D'Souza DN, Kajdasz DK, Yvengar S, Wernicke JF. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials. Women's Health 2007b; 16(8):1145-1156.
35. Haus U, Varga B, Stratz T, Späth M, Müller W. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain. Scand J Rheumatol 2000; 113:55-58.
36. Stratz T, Varga B, Muller W. The influence of depression on the effect of Tropisetron in the therapy of fibromyalgia. Z Rheumatol 2003; 62:42-45.
37. Haus U, Späth M, Färber L. Spectrum of use and tolerability of 5-HT3 receptor antagonists. Scand J Rheumatol 2004; Suppl 119:12-18.
38. Price DD, Staud R. Neurobiology of fibromyalgia syndrome. J Rheumatol 2005; 32 (Suppl 75):22-28.
39. Staud R. Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res Ther 2006; 8:208 [Epub ahead of print].
40. Holman AJ, Meyers RR. A randomized, double blind, placebo controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 2005; 52: 2495-2505.
41. Angst F, Brioschi R, Main CJ, Lehmann S, Aeschlimann A. Interdisciplinary rehabilitation in fibromyalgia and chronic back pain: a prospective outcome study. J Pain 2006; 7:807-815.
42. Arnold LM, Bradley LA, Clauw DJ, Glass JM, Goldenberg DL. Multidisciplinary care and stepwise treatment for fibromyalgia. J Clin Psychiatry 2009; 69:35.
43. Rooks DS. Talking to patients with fibromyalgia about physical activity and exercise. Curr Opin Rheumatol 2008; 20:208-212.
44. Busch A, Schachter CL, Peloso PM, Bombardier C. Exercise for treating fibromyalgia syndrome. Evid Based Nurs 2003; 6:50-51.
45. Busch AJ, Schachter CL, Overend TJ, Peloso PM, Barber KA. Exercise for fibromyalgia: a systematic review. J Rheumatol 2008; 35:130-144.
46. Marques AP, Matsutani LA, Ferreira EAG, Mendonça LLF. A fisioterapia no tratamento de pacientes com fibromialgia: uma revisão da literatura. Rev Bras Reumatol 2002; 42:42-48.
47. Valim V. Cinesioterapia no tratamento da fibromialgia. Rev Bras Reumatol 204; 44 (suplemento 1):S59-S60.
48. Hävermark AM, Langius-Eklöf A. Long-term follow up of a physical therapy programme for patients with fibromyalgia syndrome. Scand J Caring Sci 2006; 20:315-322.
49. Valim V. Epidemiologia, in: Heymann (ed). Fibromialgia e syndrome miofascial. Legnar, São Paulo/ Brasil, 2006; p. 25-29.
50. Rooks DS, Katz JN. Use of exercise in the management of fibromyalgia. J Musculoskelet Med 2002; 19:439-448.
51. Silva GA, Lage L. Ioga e fibromyalgia. Rev Bras Reumatol 2006; 46:37-39.
52. Munguía-Izquierdo D, Legaz-Arrese A. Exercise in warm water decreases pain and improves cognitive function in middle-aged women with fibromyalgia. Clin Experimental Rheumatol 2007; 25:823-830.
53. Joaquim J, Soares F, Grossi G. A randomized, controlled comparison of educational and behavioural interventions for women with fibromyalgia. Scand J Occup Ther 2002; 9:35-45.
54. Edinger J, Wohlgemut H, Krystal A, Rice J. Behavioral insomnia therapy for fibromyalgia patients. Arch Intern Med 2005; 165:2527-2535.
55. Falcão D, Alves A, Sales L, Feldman D, Leite JR, Natour J. Cognitive behavioral therapy for treatment of fibromyalgia: a randomized controlled trial. Arthritis Rheum 2004; 50 (Suppll 9):S490-S491.
56. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569-1575.
57. Nicassio PM, Shuma C, Kim J, Cordova A, Weisman MH. Psychosocial factors associated with complementary treatment use in fibromyalgia. J Rheumatol 1997; 24:2008-2013.
58. Wahner-Roedler DL, Elkin PL, Vincent A, Thompson JM, Oh TH, Loehrer LL et al. Use of complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program at a tertiary care center. Mayo Clinic Proceeding 2005; 80:55-60.
59. National Center for Complementary and Alternative Medicine. What is Complementary and Alternative Medicine? NCCAM Publication No. D156 2002.
60. Ernst E. Complementary medicine. Curr Opin Rheumatol 2003; 15:151-155.
61. Holdcraft LC, AssefiN, Buchwald D. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 2003; 17:667-683.
62. Berman BM, Ezzo J, Hadhazy V, Swyers JP. Is acupuncture effective in the treatment of fibromyalgia? J Fam Practice 1999; 48:213-218.
63. Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL. Electroacupuncture in fibromyalgia: results of a controlled trial. Br Med J 1992; 305:1249-1252.
64. Feldman D, Mariano E. Treatment of fibromyalgia with acupuncture: a randomized, placebo controlled trial of 16 weeks duration (abstract 91). Am Coll Rheumatol Meeting 2001.
65. Bramwell B, Ferguson S, Scarlet N, Macintosh ND. The use of ascorbigen in the treatment of fibromyalgia patients: a preliminary trial. Altern Med Rev 2000; 5:455-462.
66. Kartinen K, Lammi K, Hypen M, Hänninen O, Rauma AL. Vegan diet alleviates fibromyalgia symptoms. Scand J Rheumatol 2000; 29:308-313.
67. Donaldson MS, Speight N, Loomis S. Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study. Complement Altern Med 2001; 1:7.
68. Jacobsen S, Danneskiold-Samsoe B, Andersen RB. Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation. Scand J Rheumatol 1991; 20:294-302.
69. Merchant RE, Carmack CA, Wise CM. Nutritional Supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study. Phytother Res 2000; 14:167-173.
70. Merchant RE, André C. A review of recent clinical trials of the nutritional Supplementement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. Altern Ther 2001; 7:79-91.
71. Kuhara M, Alves A, Feldman D. A 12 week, randomized, controlled trial of Hypericum perfuratum and amitryptiline for the treatment of fibromyalgia. Arthritis Rheum 2004; 50(suppl 9):S490-S491.
72. Skrabek RQ, Galimova L, Ethans K, Perry D. Nabilone for the treatment of pain in fibromyalgia. J Pain 2008; 9:164-173.
73. Kiefer D, Pantuso T. Panax ginseng. Am Fam Phys 2003; 68:1539-1542.
74. Braz AS. Ensaio farmacológico clínico com extrato das raízes do Panax ginseng C.A. Meyer no tratamento da fibromialgia. Tese, 2009 p.121. Laboratório de Tecnologia Farmacêutica, da Universidade Federal da Paraíba, Brasil.
75. Kolasinski SL. Complementary and alternative therapies for rheumatic disease. Hosp Prac 2001; 36:31.